NVDA
NVIDIA
-- 146.080 TSLA
Tesla
-- 412.230 AAPL
Apple
-- 223.610 TEM
Tempus AI
-- 54.050 ARM
Arm Holdings
-- 165.700 
Tempest Receives Orphan Drug Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma (HCC)
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Just exploring the app to grow my money. Don't scold me if I'm copying u k 😂
172
Followers
39
Following
756
Visitors
Follow
Discussing
Trump 2.0 Era: What's the next opportunity in the markets?
▪️Could Trump's crypto policies potentially benefit the crypto market? ▪️Might his tariff policies have a positive effect on Chinese stocks
Michael McCarthy CCO
Jan 3 11:57
Ask a strategist - Trump's first day
104146026 : hopfully news spread out fast, price will rocket
Kit2612 : Just wondering, why is receiving orphan drug designation is a good news ? Tq